Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Julien Péron 1 Pascal Roy 1 T. Conroy Françoise Desseigne M. ychou 2 S. Gourgou-Bourgade T. Stanbury L. Roche 3 B. Ozenne 1 M. Buyse 
1 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
2 IRCM - U1194 Inserm - UM - Institut de Recherche en Cancérologie de Montpellier
3 LBBE - Laboratoire de Biométrie et Biologie Evolutive - UMR 5558
Document type :
Journal articles
Complete list of metadata
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02053624
Contributor : Lauriane Pillet Connect in order to contact the contributor
Submitted on : Friday, March 1, 2019 - 2:33:31 PM
Last modification on : Tuesday, July 5, 2022 - 10:22:55 AM

Links full text

pubmedcentral

Identifiers

Collections

CNRS | INRIA | UNIV-LYON1 | FNCLCC | VALDAURELLE | BIOENVIS | BS | UNIV-MONTPELLIER | IRCM | UDL

Citation

Julien Péron, Pascal Roy, T. Conroy, Françoise Desseigne, M. ychou, et al.. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget, Impact journals, 2016, 7, pp.82953-28960. ⟨10.18632/oncotarget.12761⟩. ⟨hal-02053624⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

26